Alogliptin

Educational summary, not a formulary. Dosing is quoted from the Makindo chapters and topics site. The other sections are draft summaries not yet checked line by line against the BNF or SPC. Check dose, indication, interactions and monitoring in the BNF entry for Alogliptin and local guidelines before prescribing.

DPP-4 inhibitor

Mechanism

DPP-4 inhibitor.

Uses

Type 2 diabetes.

Dosing

No dose is given in the chapters. See the BNF.

Side effects

Nasopharyngitis, headache, pancreatitis, hepatic effects.

Interactions

Few.

Contraindications and cautions

Pancreatitis history

Monitoring

HbA1c, LFT

Pregnancy and breastfeeding

Avoid

Renal and hepatic impairment

Reduce dose in renal impairment

Overdose and reversal

Supportive

Special advice

Reduce dose in renal impairment.

More from the textbook: uses, cautions and other points
Where it is discussed in the book